euphorbia-factor-l1 and Adenocarcinoma

euphorbia-factor-l1 has been researched along with Adenocarcinoma* in 2 studies

Other Studies

2 other study(ies) available for euphorbia-factor-l1 and Adenocarcinoma

Article	Year
Euphorbia factor L1 inhibited transport channel and energy metabolism in human colon adenocarcinoma cell line Caco-2. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Dec-31, Volume: 169 Topics: Adenocarcinoma; Adenosine Triphosphatases; Adenosine Triphosphate; Aquaporins; Caco-2 Cells; Colonic Neoplasms; Diterpenes; Energy Metabolism; Humans; Intestinal Mucosa; Molecular Docking Simulation; Permeability; Tight Junction Proteins; Tight Junctions; Transforming Growth Factor beta1	2023
Integrated Analysis of Transcriptome and microRNA Profile Reveals the Toxicity of Molecules (Basel, Switzerland), 2022, Oct-16, Volume: 27, Issue:20 Topics: Adenocarcinoma; Caco-2 Cells; Colonic Neoplasms; Diterpenes; Euphorbia; Gene Expression Profiling; Humans; Interleukin-17; MicroRNAs; RNA, Messenger; Transcriptome	2022

Article

Year

Euphorbia factor L1 inhibited transport channel and energy metabolism in human colon adenocarcinoma cell line Caco-2.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Dec-31, Volume: 169

Topics: Adenocarcinoma; Adenosine Triphosphatases; Adenosine Triphosphate; Aquaporins; Caco-2 Cells; Colonic Neoplasms; Diterpenes; Energy Metabolism; Humans; Intestinal Mucosa; Molecular Docking Simulation; Permeability; Tight Junction Proteins; Tight Junctions; Transforming Growth Factor beta1

2023

Integrated Analysis of Transcriptome and microRNA Profile Reveals the Toxicity of

Molecules (Basel, Switzerland), 2022, Oct-16, Volume: 27, Issue:20

Topics: Adenocarcinoma; Caco-2 Cells; Colonic Neoplasms; Diterpenes; Euphorbia; Gene Expression Profiling; Humans; Interleukin-17; MicroRNAs; RNA, Messenger; Transcriptome

2022